Sonali Thosani, M.D.

Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine

About Dr. Sonali Thosani

Dr. Sonali Thosani is an Associate Professor in the Department of Endocrine Neoplasia and Hormonal Disorders at the University of Texas MD Anderson and the Section Chief for Diabetes. Dr. Thosani is certified in medical quality and is the Patient Safety Quality Officer for Division of Internal Medicine and Department of Endocrinology. She is also the Operations Medical Director for the Glycemic Management Program.

She grew up in Oklahoma City and graduated Summa cum laude from Oklahoma City University with a Bachelor of Arts and Science in Spanish and Biology. After graduating from the University of Oklahoma medical school, she completed a residency training program in Internal Medicine and Pediatrics at UT-Houston, and an Endocrinology fellowship at Baylor College of Medicine.

She has been a faculty member at MD Anderson since 2012, and her clinical and research interests include treatment of diabetes and steroid induced hyperglycemia in cancer patients, and designing ways to improve the quality and delivery of health care in the inpatient and outpatient setting. Dr. Thosani is multilingual and fluent in Spanish, Hindi and Gujarati.

Primary Appointment

Professor, Endocrine Neoplasia & Hormonal Disorders, Internal Medicine, UT MD Anderson Cancer Center

Operations Medical Director-Glycemic Control, Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX

Section Chief, Diabetes, Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Professor, Endocrine Neoplasia & Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas

Adjunct Assistant Professor, Internal Medicine, Baylor College of Medicine, Houston, TX

Research Interests

Management of steroid induced hyperglycemia

Quality improvement in health care delivery

Endocrine effects of cancer chemotherapy

Clinical Interests

Dr. Thosani enjoys taking care of patients with diabetes and endocrine complications of cancer treatment including thyroid disorders, hypogonadism and bone health disorders. In addition, she work on improving the quality of care delivered to patients across various settings.

For general clinic information and referrals, please visit the Department of Endocrine Neoplasia and Hormonal Disorders' contact information webpage at:

Contact Information

Education & Training

Degree-Granting Education

2006	University of Oklahoma College of Medicine, Oklahoma City, Oklahoma, US, MD
2002	Oklahoma City University, Oklahoma City, Oklahoma, US, Spanish, BA
2002	Oklahoma City University, Oklahoma City, Oklahoma, US, Biology, BS

Postgraduate Training

2010-2012	Endocrinology Fellowship, Baylor College of Medicine, Houston, Texas
2007-2010	Medicine/Pediatrics Residency, UT Health, Houston, Houston, Texas
2006-2007	Medicine/Pediatric Internship, University of Oklahoma College of Medicine, Oklahoma, Oklahoma

Licenses & Certifications

2024	DEA Certification
2024	Basic Life Support
2024	Alabama Board of Medical Examiners
2023	Mississippi State Board of Medical Licensure
2023	Georgia Composite Medical Board
2023	Oklahoma State Board of Medical Licensure
2023	Arizona Board of Medical Examiners
2023	Tennessee Board of Medical Examiners
2023	Louisiana State Board of Medical Examiners
2023	Washington State Department of Health
2021	Florida Board of Medicine
2013	American Board of Internal Medicine, Endocrinology
2011	American Board of Pediatrics
2010	American Board of Internal Medicine, Internal Medicine
2008	Texas Medical Board

Experience & Service

Faculty Academic Appointments

Associate Professor, Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - 2026

Assistant Professor, Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2020

Administrative Appointments/Responsibilities

Physician Lead for Rapid Access to Clinics, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2025 - Present

Certified trainer for High Reliability Organization Training: Leadership Skills and Universal Skills, The University of Texas MD Anderson Cancer Center, Houston, TX, 2022

Patient Safety Quality Officer, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - 2026

Physician Lead for QAPI Hyperglycemia PFA, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - Present

Patient Safety Quality Officer, Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2025

Rotation Program Coordinator, General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2016

Rotation Program Coordinator, Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2021

EHR Officer, Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2016

Subject Matter Expert for Diabetes, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2016

Other Professional Positions

President, Texas Endocrine Association, 2026 - 2028

Board Member, Texas Endocrine Association, 2024 - Present

Vice President, Texas Endocrine Association, 2024 - 2026

Board Member of Directors, Texas Association of Clinical Endocrinology, Houston, TX, 2019 - 2023

Fellow Representative for Harris County Quality Improvement Conference, Baylor College of Medicine, Houston, TX, 2011

Chief Medical Resident, UT Health, Houston, Houston, TX, 2009 - 2010

Member of Residency Council, UT Health, Houston, Houston, TX, 2008 - 2009

Committee Member for Medical School Admissions Boards, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 2007

Extramural Institutional Committee Activities

Committee Member, UT HIP Endocrinology Clinical Workgroup, The University of Texas MD Anderson Cancer Center, 2026 - 2026

Ex-officio member, Education Oversight Committee, AACE, 2026 - Present

Chair, Clinical Effectiveness Subcommittee, The University of Texas MD Anderson Cancer Center, 2025 - 2027

Member, Oncoendocrinology Special Interest Group, Endocrine Society, 2025 - Present

Committee member, Belonging, Leadership, Opportunity, Outreach and Mentorship (BLOOM), AACE, 2025 - Present

Member, Cancer Network Quality Management Commitee, The University of Texas MD Anderson Cancer Center, 2024 - 2026

Member, ECMS, The University of Texas MD Anderson Cancer Center, 2023 - 2026

Co-chair, Clinical Effectiveness Subcommittee, The University of Texas MD Anderson Cancer Center, 2023 - 2025

MDACC Representative, UT-HIP Expert Panel, The University of Texas MD Anderson Cancer Center, 2021 - 2022

Chair, DoIM Quality Council, The University of Texas MD Anderson Cancer Center, 2020 - 2026

Vice Chair, DoIM Quality Council, The University of Texas MD Anderson Cancer Center, 2019 - 2020

Member, Continuing Medical Education Committee, The University of Texas MD Anderson Cancer Center, 2018 - 2020

member, DoIM QI council, The University of Texas MD Anderson Cancer Center, 2013 - 2019

Member, Clinical Effectiveness Subcommittee, The University of Texas MD Anderson Cancer Center, 2012 - 2015

Editorial Activities

Editorial Board Member, Journal of diabetes science and technology, 2026 - Present

Honors & Awards

2026	Committment to Mentoring Award, UT MD Anderson
2026	Division of Internal Medicine Retreat Quality Improvement Poster Award - 1st prize, UT MD Anderson Cancer Center
2025 - Present	Fellow of the American Association of Clinical Endocrinology, American Association of clinical Endocrinology
2024	Quality improvement Poster Competition, DoIM Research Retreat 2024
2023 - Present	Fellow of endocrine Alliance Academy, Endocrine Alliance
2023	Award for Professionalism Excellence (APEX), Center for Professionalism Support and Success (CPSS) MD Anderson
2023	Graduate of LEADing Teams Core Cohort-June, MD Anderson Leadership Institute
2021	Division of Internal Medicine Excellence in Quality Improvement Award, Division of Internal Medicine
2021	Six Sigma Yellow Belt Certification
2021	Presidential Recognition of Excellence in Clinical Quality Improvement, UT MD Anderson
2019	Quality Improvement Poster finalist, Division of Internal Medicine Research Retreat
2012	Women in Endocrinology, Young Investigator Award, Endocrine Society
2010	American Association of Clinical Endocrinology - Fellows in Training Representative, American Association of Clinical Endocrinology
2009	Humanism in Medicine Award, OU College of Medicine
2006 - Present	Presenter of Humanism in Medicine, OU College of Medicine
2006 - Present	Presenter for Finalist in Dean’s Award, OU College of Medicine
2006	Finalist for Dean’s Award, OU College of Medicine

Professional Memberships

American Society for Bone and Mineral Research

2020 - 2023

American College of Medical Quality

2019 - 2023

International Society of Clinical Densitometry

2015 - 2018

American Diabetes Association

2013 - Present

Women in Endocrinology

2012 - 2020

American Association of Clinical Endocrinologists

2011 - Present

American Thyroid Association Member

2011 - 2013

Endocrine Society

2010 - Present

Selected Presentations & Talks

Local Presentations

2025. Quality in Action: The Journey to Joint Commission Certification for Inpatient Diabetes. Invited. Quality Improvement Grand Rounds. Houston, Texas, US.
2025. Quality Improvement Council Update 2025. Invited. Quality Improvement Grand Rounds. Houston, Texas, US.
2025. Triple Threat: Diabetes, Cancer and Cardiovascular Disease. Invited. Cardiology Grand Rounds. Houston, Texas, US.
2025. Pitfalls in Point of Care Glucose Monitoring. Invited. DM Academic Meeting. Houston, Texas, US.
2025. Insulin Pump Therapy and CGM use in the Oncology Patient. Invited. Diabetes Lecture Series. Houston, Texas, US.
2023. 2023 Updates. Conference. Quality Improvement Council. Houston, Texas, US.
2021. Inpatient Glycemic Management at MD Anderson: the past, the present, and the future!. Invited. DoIM Grand Rounds. Houston, Texas, US.
2021. Diabetes and Hyperglycemia Management in Cancer Patients. Conference. Houston, TX, US.
2021. Hypoglycemia: "The Biggest Barriers to Hyperglycemia Treatment". Invited. Education Series. Houston, Texas, US.
2021. Glycemic Management Action Team: Update and Future Plans. Invited. Glycemic Management Action Team: Update and Future Plans. Houston, TX, US.
2020. Quality and Safety Report. Invited. Cancer Survivorship Grand Rounds. Houston, Texas, US.
2020. Glycemic Management Action Team: update and future plans. Invited. DoIM Grand Rounds. Houston, Texas, US.
2020. 2020 Division of Internal Medicine Quality and Safety Report. Invited. 2020 Division of Internal Medicine Quality and Safety Report. Houston, TX, US.
2019. ICT Grand Rounds. Invited. ICT Grand Rounds. Houston, Texas, US.
2017. Improving Documentation and Management of Hypoglycemia through Protocol Adherence: A Quality Improvement Initiative. Conference. Improving Documentation and Management of Hypoglycemia through Protocol Adherence: A Quality Improvement Initiative, US.
2014. Peri-operative Glycemic Management in Cancer Patients. Invited. Anesthesia Grand Rounds. Houston, Texas, US.
2013. Improvement of Hypoglycemia Management in Hospitalized Patients:. Conference. Improvement of Hypoglycemia Management in Hospitalized Patients:, US.

Regional Presentations

2023. Setting up a Remote CGMS clinic: Enhancing patient Care and practice efficiency. Conference. Setting up a Remote CGMS clinic: Enhancing patient Care and practice efficiency. Houston, US.
2023. Sweet Success: Implementation of House Wide Glycemic Initiative. Conference. Sweet Success: Implementation of House Wide Glycemic Initiative, US.
2021. Endocrine adverse effects of Immunotherapy. Conference. Endocrine adverse effects of Immunotherapy. San Antonio, TX, US.
2018. Diabetes and Cancer Risk. Conference. Diabetes and Cancer Risk. Houston, US.

National Presentations

2026. Impact of Preoperative Insulin Education on Outcomes After Total Pancreatectomy. Poster. Association of Diabetes Care Education Specialists annual conference. columbus, ohio, US.
2026. Metabolic Consequences of Cancer Therapy. Invited. Meet the Expert Session. New Orleans, Louisiana, US.
2026. Utilizing Diabetes Technology for Optimizing Care. Invited. Primary Care Conferences. San Diego, California, US.
2026. Insulin therapy for Diabetes Management. Invited. Primary Care Conferences. San Diego, California, US.
2026. Osteoporosis Update 2026. Invited. Primary Care Conferences. San Diego, California, US.
2026. Type 2 Diabetes Mellitus: 2026 Update. Invited. Primary Care Conferences. San Diego, California, US.
2025. CGM Measurement. Panelist. Diabetes Therapeutics Technology Meeting. Burlingame, California, US.
2025. Integrating Quality Improvement into Inpatient Diabetes Care. Invited. Meet the Professor Session. San Francisco, California, US.
2025. Finding the sweet spot: Achieving Glucose control in patients on Nutrition Support Therapy. Invited. American Society of Parenteral and Enteral Nutrition. Columbus, Ohio, US.
2024. Type 2 DM Update 2024. Invited. MER Conference. Orlando, Florida, US.
2024. Osteoporosis Update 2024. Invited. MER Conference. Orlando, Florida, US.
2024. Update on Type 1 Diabetes and Insulin Therapy. Invited. MER Conference. Orlando, Florida, US.
2024. 2024 Update in Thyroid Disorders. Invited. MER Conference. Orlando, Florida, US.
2024. Hyperglycemia Management in Nutrition Support Patients. Invited. American Society for Parenteral and Enteral Nutrition (ASPEN) meeting. Tampa, FL, US.
2023. Integrating Quality Improvement into Clinical Practice. Conference. Integrating Quality Improvement into Clinical Practice. Seattle, WA, US.
2021. Endocrine adverse effects of Immunotherapy. Conference. San Antonio, TX, US.
2020. Obesity Management Update 2020. Visiting. MER Conference. Nassau, BS.
2020. Type 2 Diabetes Mellitus. Visiting. MER Conference. Nassau, BS.
2020. Management of Dyslipidemia. Visiting. MER Conference. Nassau, BS.
2020. Insulin Therapy for Diabetes. Visiting. MER Conference. Nassau, BS.
2018. Immunotherapy induced insulin dependent diabetes: a cancer center experience. Conference. Immunotherapy induced insulin dependent diabetes: a cancer center experience, US.
2014. Management of Steroid induced hyperglycemia in Cancer Patients. Conference. Oncologic Care of Cancer Patient, US.
2011. Pseudohypoparathyroidism and Increased Bone Mineral Density. Conference. Pseudohypoparathyroidism and Increased Bone Mineral Density, US.
2011. Severe Constipation and Uncontrolled Hypertension. Conference. Severe Constipation and Uncontrolled Hypertension, US.

Formal Peers

2026. Perioperative Diabetes Management. Houston, Texas, US.
2025. Insulin Pump Therapy and CGM use int he Oncology Patient. Houston, Texas, US.
2024. Characterizing ICI-induced diabetes, US.
2024. Insulin Pump Therapy and CGMs in the Oncology Patient. Houston, Texas, US.
2023. Diagnosis and Management of patients with type 1 Diabetes and Insulin Pump. Houston, Texas, US.
2023. What's New in DKA Management. Houston, Texas, US.
2023. HRO Universal Skills Course. Houston, Texas, US.
2023. Management of Type 1 Diabetes and Insulin Therapy. Visiting. Washington, DC, US.
2023. Osteoporosis Update. Visiting. Washington, DC, US.
2023. Update on Thyroid Disease Management. Visiting. Washington, DC, US.
2023. Update on Type 2 Diabetes Management. Visiting. Washington, DC, US.
2023. Management of Patients with Type 1 diabetes and Cancer, US.
2022. Osteoporosis: Diagnosis and Management in 2022. Conference. Newport, RI, US.
2022. Insulin Therapy, Injectables and Diabetes Technology in 2022. Conference. Newport, RI, US.
2022. Type 2 diabetes mellitus: Diagnosis and Management. Conference. Newport, RI, US.
2022. Thyroid Disorders in Women: Diagnosis and Management (2022). Conference. Newport, RI, US.
2022. Universal Skill Course. HRO Training. Houston, Texas, US.
2022. Management of Hyperglycemic Emergencies. Houston, Texas, US.
2022. Optimizing Glycemic Management in Cancer Patients. Houston, Texas, US.
2022. Improving Hyperglycemia management in Pediatric patients. Houston, Texas, US.
2022. Inpatient Hyperglycemia Management in Cancer Patients. Houston, Texas, US.
2022. Leadership skills. High reliability Organizational Training. Houston, Texas, US.
2022. Universal Skills. High Reliability Organizational Training. Houston, Texas, US.
2022. Endocrine Case Conference. Conference. Oahu, HI, US.
2022. Insulin Treatment in Diabetes. Conference. Oahu, HI, US.
2022. Type 2 Diabetes. Conference. Oahu, HI, US.
2022. Thyroid Disorders. Conference. Oahu, HI, US.
2022. Endocrinology Case Reviews. Conference. Oahu, HI, US.
2022. Diagnosis and Management of Type 2 diabetes mellitus: 2022 update. Conference. Oahu, HI, US.
2022. Insulin Therapy, Diabetes Technology and Injectables in 2022. Conference. Oahu, HI, US.
2022. Thyroid Disorders in Women: Diagnosis and Management. Conference. Oahu, HI, US.
2022. Osteoporosis: Comprehensive Update 2022. Conference. Oahu, HI, US.
2022. Osteoporosis: Diagnosis and Treatment. Conference. Oahu, HI, US.
2022. Presentation on Diabetes and Cancer Patient. Houston, Texas, US.
2022. Hyperglycemia Management in Cancer patient. Houston, Texas, US.
2022. Leadership skills. High reliability Organizational Training. Houston, Texas, US.
2022. Universal Skills. High Reliability Organizational Training. Houston, Texas, US.
2022. Improving hyperglycemia management at MD Anderson. Houston, Texas, US.
2022. Update on Glycemic Management Policy and Hyperglycemia Algorithm. Houston, Texas, US.
2021. Improving hyperglycemia management at MD Anderson. Houston, Texas, US.
2021. Inpatient Diabetes Management: What's new?. Houston, Texas, US.
2021. Perioperative Management of Hyperglycemia. Houston, Texas, US.
2021. Barriers and Special Populations in a Cancer Hospital for Inpatient Glycemic Management. Houston, Texas, US.
2021. Multidisciplinary approach to improving glucose management in patients at high risk of DKA. Houston, Texas, US.
2021. Hyperglycemic Emergencies in Cancer Patients. Houston, Texas, US.
2020. Outpatient and Perioperative Diabetes Management. Visiting. Houston, TX, US.
2020. Immunotherapy Induced Endocrinopathies. Houston, Texas, US.
2020. Endocrine Case Conference: Hyperglycemic Emergencies. Visiting. Houston, TX, US.
2020. Immunotherapy Induced Endocrinopathies. Visiting. Houston, TX, US.
2020. Management of Hyperglycemia and Hyperglycemic Emergencies. Houston, Texas, US.
2020. DKA/HHS Management - Hyperglycemic Emergencies. Houston, Texas, US.
2020. A Multidisciplinary Approach to Prevent Hyperglycemic Emergencies in High-Risk Patients. Houston, Texas, US.
2020. Encounters with Hyperglycemic Cancer Patients in the Emergency Room. Houston, Texas, US.
2020. Project proposal: Quality Assessment Performance Improvement (QAPI) Board. Houston, Texas, US.
2019. Case Presentations: Calcium Disorders 2019 update. Conference. Orlando, FL, US.
2019. Osteoporosis Update 2019. Conference. Orlando, FL, US.
2019. Osteoporosis Update 2019. Conference. Washington DC, US.
2019. Thyroid Disorders in Women. Conference. Washington DC, US.
2019. Calcium Disorders. Conference. Washington DC, US.
2019. Calcium Disorders: Case Presentations. Washington, DC, US.
2019. Endocrine Side Effects of Immunotherapy. Houston, Texas, US.
2019. Hyperglycemic Emergencies in the ICU. Houston, Texas, US.
2019. General Outpatient Management Highlighting Checkpoints. Houston, Texas, US.
2018. Osteoporosis Management for Primary Care Physicians. Conference, US.
2018. Metabolic Bone Disease. Conference. Hilton Head, SC, US.
2018. Case Presentations: Calcium Disorders. Conference. Hilton Head, SC, US.
2018. Disorders of Calcium Metabolism. Conference. Hilton Head, SC, US.
2018. Osteoporosis Update 2018. Conference, US.
2018. Management of Obesity: 2018 update. Conference. Los Angeles, CA, US.
2018. Thyroid Disorders in Women. Conference, US.
2018. Case Presentations: Obesity Management and Osteoporosis. Conference. Los Angeles, CA, US.
2017. Endocrine Board Review. Houston, Texas, US.
2016. Diagnosis and Management of Hypothyroidism. Houston, Texas, US.
2016. Diagnosis and Management of Hyperthyroidism. Houston, Texas, US.
2016. Diagnosis and Management of Hypothyroidism. Houston, Texas, US.
2015. Management of Hyperglycemia in Cancer Patients. Houston, Texas, US.

Less

Grant & Contract Support

Date:	2021 - 2025
Title:	PET Imaging of ROS Burst in Immune Adverse Events: First-in-Human Evaluation
Funding Source:	NIH
Role:	OSC
ID:	PA-20-183

Selected Publications

Peer-Reviewed Articles

Osafehinti DA, Thosani S, Weitzman SP. Trends in Glycemia Risk Index Over Time in Patients With Diabetes and Cancer Undergoing Remote Continuous Glucose Monitoring. J Diabetes Sci Technol:19322968261470745, 2026. e-Pub 2026. PMID: 42490146.
Gandhi A, Jeun R, Wang Z, Khan S, Best CJ, Lavis VR, Thosani S. Etiologies and Outcomes of Diabetic Ketoacidosis in Cancer Patients. Cancers 17(17), 2025. e-Pub 2025. PMID: 40940823.
Kotian A, Cain K, Moser T, Patel R, Warren ML, Thosani S. Decreasing Insulin Induced Hypoglycemia with Education of a New Multimodal Hyperkalemia Order Set for Patients Admitted to a Cancer Center. Journal of Oncology Pharmacy Practice, 2025. e-Pub 2025. PMID: 40718910.
Berkman AM, Andersen CR, Dixon SB, Ramirez A, Gilmore K, Thoman W, Razouki ZA, Santos D, Thosani S, Livingston J, T Hildebrandt MA, Roth ME. Weight-Related Outcomes among Survivors of Adolescent and Young Adult Cancer after Anti-Obesity Medication Initiation. Journal of Adolescent and Young Adult Oncology, 2025. e-Pub 2025. PMID: 40452567.
Moussa MJ, Wilson NR, Ghosh A, Bhattacharjee M, Curry JL, Cho WC, Patel A, Habra MA, Thosani S, Campbell M, Siefker-Radtke AO, Alhalabi O, Kikani NJ. Systemic Toxicity With Hyperglycemia or Diabetic Ketoacidosis After Enfortumab Vedotin. Annals of Internal Medicine Clinical Cases 4(5), 2025. e-Pub 2025.
Taylor JS, Fellman B, Cain K, Iniesta-Donate M, Earles T, Harris M, James DA, Siebel C, Lasala J, Mena GE, Raty S, Popovich SM, Vu KD, Thosani S, Best CJ, Schmeler KM, Ramirez PT, Meyer LA. Glycemic control to improve post-operative outcomes in patients with type 2 diabetes mellitus. International Journal of Gynecological Cancer 35(1), 2025. e-Pub 2025. PMID: 39878292.
Parikh K, Thosani S, Joshi A, Hajirnis A, Seth C. A retrospective study of 5S behaviours of Physical Activity (PA) among suburban Mumbai population with Type 2 Diabetes Mellitus (T2DM). J Family Med Prim Care 14(1):247-253, 2025. e-Pub 2025. PMID: 39989523.
Taylor J, Fellman B, Raty S, Lasala J, Iniesta M, Cain K, Horner A, Bruno M, Folloder J, Knippel S, Khanh V, Popovich S, Katz M, Best C, Thosani S. Detection and Management of Perioperative Hyperglycemia at a Tertiary Cancer Center. Annals of Surgical Oncology 31(5):3017-3023, 2024. e-Pub 2024. PMID: 38347330.
Jeun R, Iyer PC, Best C, Lavis V, Varghese JM, Yedururi S, Brady V, Glitza Oliva IC, Dadu R, Milton DR, Brock K, Thosani S. Clinical Outcomes of immune checkpoint inhibitor diabetes mellitus at a comprehensive cancer center. Immunotherapy 15(6):417-428, 2023. e-Pub 2023. PMID: 37013834.
Jeun R, Lavis VR, Thosani S. Diabetic Ketoacidosis With Alpelisib. Journal of Endocrine Society 5(1), 2021. e-Pub 2021. PMID: 8089606.
Jeun R, Lavis V, Thosani S. Diabetic Ketoacidosis upon Initiation of Alpelisib: Two Case Reports. Clinical Oncology Case Reports 4(3), 2021. e-Pub 2021.
Jozaghi Y, Zafereo M, Perrie ND, Wang JR, Grubbs E, Gross ND, Fisher S, Sturgis EM, Goepfert RP, Lai SY, Best CJ, Busaidy NL, Cabanillas ME, Dadu R, Gagel RF, Habra MA, Hu M, Jimenez C, Sherman S, Thosani S, Varghese J, Waguespack S, Weitzman S, Ying AK, Graham PH. Endocrine surgery in the Coronavirus disease 2019 pandemic: Surgical Triage Guidelines. Head & Neck 42(6):1325-1328, 2020. e-Pub 2020. PMID: 32437031.
Bedrose S, Turin CG, Lavis VR, Kim ST, Thosani S. A case of acquired generalized lipodystrophy associated with Pembrolizumab in a patient with metastatic malignant melanoma. AACE Clinical Case Reports 6(1):e40-e45, 2020. e-Pub 2020. PMID: 32524008.
Iyer P, Cabanillas M, Waguespack S, Hu M, Thosani S, Lavis V, Busaidy N, Subudhi S, Diab A, Dadu R. Immune-Related Thyroiditis with Immune Checkpoint Inhibitors. Thyroid 10:1243-1251, 2018. e-Pub 2018. PMID: 30132401.
Pinnix CC, Cella L, Andraos TY, Ayoub Z, Milgrom SA, Gunther J, Thosani S, Wogan C, Conson M, D'Avino V, Oki Y, Fanale M, Lee HJ, Neelapu S, Faya L, Hagemeister F, Robriguez MA, Nastoupil LJ, Nieto Y, Qiao W, Pacelli R, Dabaja B. Predictors of Hypothyroidism in Hodgkin Lymphoma Survivors After Intensity Modulated Versus 3-Dimensional Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics 101(3):530-540, 2018. e-Pub 2018. PMID: 29681481.
Thosani S, Ayala-Ramirez M, Roman-Gozalez A, Zhou S, Thosani N, Bisanz A, Jimenez C. Constipation: an overlooked, unmanaged symptom of patients with pheochromocytoma and sympathetic paraganglioma. European Journal of Endocrinology 173(3):377-87, 2015. e-Pub 2015. PMID: 26060051.
Brady V, Thosani S, Zhou S, Bassett R, Busaidy N, Lavis V. Safe and effective dosing of basal-bolus insulin in patients receiving high-dose steroids for hyper-cyclophosphamide, doxorubicin, vincristine, and dexamethasone chemotherapy. Diabetes Technology & Therapeutics 16(12):874-9, 2014. e-Pub 2014. PMID: 25321387.
Thosani S, Ayala-Ramirez M, Hu M, Palmer L, Rich T, Gagel R, Cote G, Waguespack SG, Habra MA, Jimenez C. The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2. The Journal of Endocrinology and Metabolism 98(11):E1813-19, 2013. e-Pub 2013. PMID: 24030942.

Invited Articles

Best CJ, Thosani S, Ortiz M, Levesque C, Varghese S, Lavis VR. Co-Managing Patients with Type 1 Diabetes and Cancer. Current Diabetes Reports 16(8):73, 2016. e-Pub 2016. PMID: 27319323.
Thosani S, Hu M. Denosumab: a new agent in the management of hypercalcemia of malignancy. Future Oncology 11(21):2865-71, 2015. e-Pub 2015. PMID: 26403973.

Review Articles

Iyer PC, Kikani NJ, Khan S, Chaudhari A, Pagnotti GM, Best CJ, Weitzman SP, Mehta PB, Lavis VR, Thosani S, Gandhi A, Aguirre RS, Varghese J, Guise TA, Dadu R. The evolving management of endocrine disorders induced by checkpoint inhibitors. Expert Review of Endocrinology and Metabolism 21(1):29-41, 2026. e-Pub 2026. PMID: 41307239.
Kotwal A, Kennedy R, Thosani S, Kikani N, Goldner W, Shariff A. Endocrinopathies Associated With Immune Checkpoint Inhibitor Use. Endocrine Practice 30(6):584-591, 2024. e-Pub 2024. PMID: 38554775.
Jimenez P, Tatsui C, Jessop A, Thosani S, Jimenez C. Treatment for Malignant Pheochromocytomas and Paragangliomas: 5 Years of Progress. Current Oncology Reports 19:83, 2017. e-Pub 2017. PMID: 29081018.
Thosani S, Jimenez C. Opioid-induced biochemical alterations of the neuroendocrine axis. Expert Review of Endocrinology & Metabolism 6(5):705-703, 2014. e-Pub 2014. PMID: 30780884.
Yeung Ching-Sai, Habra MA, Thosani S. Lung cancer-induced paraneoplastic syndromes. Current Opinion in Pulmonary Medicine 17(4):260-8, 2011. e-Pub 2011. PMID: 21577115.
Thosani N, Thosani S, Qiao W, Fleming JB, Bhutani MS, Guha S. Role of EUS-FNA-based cytology in the diagnosis of mucinous pancreatic cystic lesions: a systematic review and meta-analysis. Digestive Diseases and Sciences, 2010. e-Pub 2010. PMID: 20694512.
Pollard LM, Sharma R, Gómez M, Shah S, Delatycki MB, Pianese L, Monticelli A, Keats BJ, Bidichandani SI. Replication-mediated instability of the GAA triplet repeat mutation in Friedreich ataxia. Nucleic Acids Research, 2004. e-Pub 2004. PMID: 15534367.

Professional Educational Materials

Thosani S. Optimizing Nursing Workflow for Comprehensive Inpatient Diabetes Education and Care. MD Anderson Cancer Center, 2025.
Thosani S. Diabetes Survival Skills: Essential Knowledge for Patient Teaching in Managing Diabetes During Cancer Treatment. MD Anderson Cancer Center, 2025.
Thosani S. Teaching Patients Glucometer Use and Insulin Therapy. MD Anderson Cancer Center, 2025.
Thosani S. Diabetes Management: Practice Pearls for the Impatient Oncology Nurse. MD Anderson Education Center, 2024.
Thosani S. Basal Bolus insulin therapy. MD Anderson Education Center. MD Anderson Education Center, 2021.
Thosani S. Hyperglycemic Emergencies: DKA and HHS. MD Anderson Education Center, 2020.
Thosani S. Caring for Patients with Insulin Pumps. MD Anderson Education Center, 2020.
Thosani S. Diabetes Mellitus. MD Anderson Education Center, 2020.
Thosani S. Hypoglycemia: Accurately managing and documenting hypoglycemia treatment in Hospitalized patients. MD Anderson Cancer Center, 2017.

Editorials

Thosani S. Psychological Safety in Healthcare: A Pre-requisite for High Reliability. ACE-Qi, 2026.

Abstracts

Asfandiyar S, Kaplan J, Rao A, Palma D, Thosani S. CDCES-Led Hybrid Diabetes Education and Universal CGM Pathway Associated with Improved HbA1c After Total Pancreatectomy in a Tertiary Cancer Center. 22nd International Congress of Endocrinology, 2026.
Asfandiyar S, Kaplan J, Rao A, Palma D, Thosani S. CDCES-Led Hybrid Diabetes Pathway Reduces Hospitalizations and Improves Glycemic Outcomes After Total Pancreatectomy. 2nd Annual Cancer Nursing Conference: Transforming Cancer Nursing Care through Quality Improvement, Evidence-Based Practice, and Research, 2026.
Jameel F, Tryels K, Grami P, Petershagen C, Balajadia B, Acob D, Millil J, Garcia R, Mathew J, Sangalang K, Jackson R, Sony S, Giang K, Febryani I, Mathew V, Tucker C, Anderson J, Lefler C, Ruiz C, Williams D, Yee C, Guk Ong B, Acker K, Vasallo L, Doran E, Gore S, Hughes C, Crowder V, Demla A, Sims D, Serrano G, Kimberley J, Thosani S. From Assessment to Action: Improving Diabetes Survival Skills Education Through Tailored Nursing Interventions. 2nd Annual Cancer Nursing Conference: Transforming Cancer Nursing Care through Quality Improvement, Evidence-Based Practice, and Research, 2026.
Thosani S, Asfandiyar S, Palma D, Rao A, Kaplan J. Preoperative Diabetes Education for Total Pancreatectomy Patients Reduces Glucose-Related Hospitalizations and Improves Glycemic Control. AACE, 2026.
Osafehinti D, Thosani S, Weitzman S. Investigating Glycemic Risk Index Trends for Patients with Comorbid Cancer and Diabetes Evaluated in Remote Monitoring Clinic. Diabetes Therapeutics and Technology Meeting, 2025. e-Pub 2025.
Gandhi A, Jeun R, Khan S, Best C, Lavis L, Thosani S. Diabetic Ketoacidosis in Cancer Patients: Etiological Patterns in a Tertiary Care Center. Endocrine Society Meeting, 2025. e-Pub 2025.
Mehta P, Gore S, Bassett R, Guk-Ong B, Mathew J, Millil J, Lalani S, Balajadia B, Grami P, Mathew S, Thosani S. Evaluating Patient Experience of Diabetes Care Services. American Association of Clinical Endocrinology Meeting, 2025. e-Pub 2025.
Donovan D, Highsmith E, Khan S, Thosani S, Horng M. Impact of decision support tool on ICU Rebound hyperglycemia. American Association of Clinical Endocrinology Meeting, 2025. e-Pub 2025.
Thosani S. Integrating Obesity Screening and Management in Cancer Survivorship Care. American Society of Metabolic and Bariatric Surgery, 2024. e-Pub 2024.
Thosani S. Enhancing Toxocity Monitoring for Patients with Advanced Thyroid Cancer on Targeted Therapy. ENDO 2024, 2024. e-Pub 2024.
Thosani S, Hamidi S, Castellanos L, Best C, Sherman S, Dadu R, Brinkman A, Khoja M, Hu M, Waguespack S, Weitzman S. Real-Life Safety Monitoring for Patients with Advanced Thyroid Cancer on Targeted Therapy: A Quality Improvement Project. Endocrine Society, 2024. e-Pub 2024.
Thosani S, Thomas W, Gilmore K, Kazantsev T, Garcia W, Warr H, Chapman P, Basen-Engquist K, Bevers T, Chang L, Crawford K, Crowder R, Hwang J, Lopez G, Morse M, Rodriquez M, Sukumar J, Roth M, Santos D. Integrating Obesity Screen and Managements in Cancer Survivorship Care. ASMBS Conference, 2024. e-Pub 2024.
Monroy A, Khan S, Kikani N, Brady VJ, Thosani SN. Hyperglycemia in a novel CDK2 and CDK9 inhibitor- Fadraciclib, 2024. e-Pub 2024.
Thosani S, Crowder V, Grami P, and Kikani N. Sweet success: Implementation of institution wide glycemic management initiative, 2024. e-Pub 2024.
Kikani N, Palma D, Brady VJ, Thosani SN. Use of Continuous Glucose Monitoring System versus Capillary Point of care testing for inpatient Glucose monitoring in a cancer hospital. Poster Presentation, 2024. e-Pub 2024.
Patil M, Thosani S, Wang Z, Bassett R, Guise T. Treatment with denosumab for osteoporosis with Metastatic disease to bone is associated with hypercalcemia. American Society of Bone and Mineral Research, 2023. e-Pub 2023.
Ngo E, Thosani S. Covid-19 Outcomes in Cancer Patients with Diabetes. Poster presentation. Endocrine Society, 2023. e-Pub 2023.
Thosani S, Kikani N. Identifying Trends in Glycemic Management in a Comprehensive Cancer Center. Division of Internal Medicine Research Retreat, 2023. e-Pub 2023.
Nguyen, Son, Thosani S. Enfortumab Vedotin associated refractory diabetic ketoacidosis, rash and altered mental status. Poster presentation, 2023. e-Pub 2023.
Ngo E, Thosani S. Neurologic and Clinical Manifestations of Cancer Patients with Checkpoint Inhibitor Diabetes and GAD65 Antibody Positivity, 2023. e-Pub 2023.
Thosani S. Denosumab Withdrawal Is Associated With Hypercalcemia In Adults With Osteoporosis And Bone Metastases, 2023. e-Pub 2023.
Kikani N, Thosani S. Identifying Trends in Glycemic Management in the Acute Cancer Care Center at MD Anderson Cancer Center. Emergency Medicine Oncology Conference, 2023. e-Pub 2023.
Thosani SN, Laura K, Neetha J. Standardizing glycemic management in high risk patients going for outpatient procedure. American College of Medical Quality Seminar, 2022. e-Pub 2022.
Palma D, Thosani S. Quality improvement project on streamlining inpatient diabetes supplies for survival skill education and discharge planning, 2022. e-Pub 2022.
Thosani S, Jawe N. Optimizing standardized workflow for identification, monitoring and treatment of Patients with Type 1 diabetes or pumps undergoing outpatient procedures. Division of Internal Medicine research Retreat, 2022. e-Pub 2022.
Taylor J, Felman B, Cain K, Iniesta M, Thosani SN, Earles T, Harris M, Raty S, Popovich S, Vu K, Best C, Schmeler K, Ramirez P, Meyer L. Surgical Universal euGlycemic Attainment during Recovery (SUGAR) Initiative: Sweet results through quality improvement. Annual Meeting on Womens Cancer, 2022. e-Pub 2022.
Taylor J, Raty S, Lasala J, Iniesta M, Cain K, Horner A, Bruno M, Folloder J, Knippel S, Khanh V, Popovich S, Katz MH, Best C, Thosani S. Surgical Universal euGlycemic Attainment during Recovery (SUGAR Initiative): Sweet Results Through Standardization, Poster presentation, 2021. e-Pub 2021.
Varghese S, Best C, Thosani S. Improving Hyperglycemia by Increasing the use of Basal Bolus Insulin Therapy. Division of Internal Medicine Research retreat, 2021.
Jeun R, Yedururi S, Lavis V, Best C, Varghese J, Glitza IC, Thosani S. Pancreatic volumes in immune checkpoint inhibitor-induced diabetes. American Society of Clinical oncology, 2021. e-Pub 2021.
Jeun R, Thosani S. Causes of Diabetic Ketoacidosis among Adults Admitted to a Comprehensive Cancer Center, 2021. e-Pub 2021.
Thosani S, Raty S, Gaeta S, Chen K, Taylor J, Thomas L, Weschler A, Horner A, Bowe C, Cavalier J, Benitez S, Gumban D, Folloder J, Drew T, Mart D, Shin D, Giang K, Monroe S, Koom-Dadzie K, Rajkot N, Richardson G, Tran J, Mathew J, Best C, Brady V, Lavis V, Wilson M, Levesque C, Ortiz M, Varghese J, Varghese S, Crowder V, John B, Ong J, Verallo C, Fajardo J, Ta-Ekasingh M, Parlikh M, Grami P, Kaur H, Estrella J, Bruno J, Horng M, Moser T, Walton N, Nugent A, Johnson C, Popat U, Rizk M, Novicke B, DeCarlo R, Ali E, McCollough R, Warren M, Lopez K, Marts D, Goldschmidt P, Rice J, Zaghian M, Stone D, Kaufman L, Jawe N. Glycemic Action team (GlyCAT): reducing inpatient DKa in cancer patients. Institute of Healthcare Improvement Forum, 2021. e-Pub 2021.
Taylor J, Raty S, Khanh V, Popovich S, Best C, Kahn S, Thosani S. Surgical euGlycemic Attainment during Recovery (SUGAR Initiative): Sweet Results Through Standardization, 2021. e-Pub 2021.
Jeun R, Best C, Iyer P, Lavis V, Varghese J, Glitza O, Dadu R, Thosani S. Immune Checkpoint Inhibitor Mediated Insulin Dependent Diabetes: Observations at a Cancer Center, 2021. e-Pub 2021.
Jeun R, Lavis V, Thosani ST. DKA with Alpelesib. Endocrine Society, 2021. e-Pub 2021.
Wilson M, Zaghian M, Rice J, Warren ML, Joylynmae, Estrella, Parikh M, Stone D, Verallo C, Kaur H, Lopez K, Ong J, Ta-Ekasingh M, Fajardo J, Grami P, Gaeta S, Lavis V, Best C, Thosani S. Improving Identification and Documentation of Patients utilizing insulin pumps at MD Anderson Cancer Center. Diabetes Therapeutics and Technology Meeting, 2020. e-Pub 2020.
Thosani SN, Brady V. Prevalence of diabetes and hyperglycemia among cancer patients see in Emergency Department. Oncology emergency Medicine conference, 2020. e-Pub 2020.
Thosani S, Best C, Lavis V, Habra M, Busaidy N, Varghese J, Hu M, Cabanillas M, Dadu R, Gagel R, Sherman S, Waguespack S, Weitzman S, Jimenez C, Levesque C, Wilson M, Ortiz M, Varghese S, Crowder V, Williams J, Feng C, Cue L, Cain K, Dang J, Simien B, Velasquez J. Improving Documentation for Hypoglycemia Treatment in Hospitalized Patients at MD Anderson Cancer Center: 2012-2019, 2019.
Taylor JS, Cain KC, Earles TR, Harris M, James D, Dottino J, Stewart K, McGrew L, Siebel C, Enbaya A, Donate M, Vacchani S, Lasala J, Thosani SN, Best C, Sahai S, Schlemer K, Ramirez P, Meyer L. Integration of a standardized Diabetic Management Protocol into an ERAS program, 2019. e-Pub 2019.
Taylor JS, Cain KC, Earles TR, Harris M, James D, Dottino J, Stewart K, McGrew L, Siebel C, Enbaya A, Donate M, Vacchani S, Lasala J, Best C, Sahai S, Schlemer K, Ramirez P, Meyer L, Thosani SN. Sugar Universal euGlycemic Attainment during Recovery Initiative (SUGAR). Institute of Healthcare Improvement, 2018. e-Pub 2018.
Iyer PI, Thosani SN. Euglycemic DKA as an initial presentation of Immunotherapy induced diabetes. American Diabetes Association, 2018. e-Pub 2018.
Iyer P, Best C, Lavis V, Varghese J, Glitza I, Dadu R, Thosani SN. Immunotherapy induced insulin dependent diabetes: a cancer center experience. American Diabetes Association, 2018. e-Pub 2018.
Cillo M, Thosani S. External Radiation Therapy: A rare Cause of Thyroiditis. American Thyroid Association Meeting, 2017.
Kariuki N, Thosani SN. Sclerosing mucoepidermoid carcinoma of the thyroid: A management predicament. Endocrine Society 2017, 2017. e-Pub 2017.
Iyer P, Thosani SN. Immunotherapy induced Type 1 DM, 2016. e-Pub 2016.
Thosani SN, Brady V, Cain K, Tran D, Cue L, Rollins J, Klimt B, Lavis V. Improving treatment of hypoglycemia inHospitalized cancer patients on insulin therapy through increased utilization of hypoglycemia Order set, 2015. e-Pub 2015.
Thosani SN, Brady V. Safe and Effective Dosing of Basal-Bolus Insulin on patients, 2014. e-Pub 2014.
Mulukutla, Surya, Thosani SN. Hypoglycemia As the Initial Presentation of Gastrointestinal Stromal Tumor, 2014. e-Pub 2014.
Dadu R, Devine C, Hernandez M, Busaidy N, Waguespack S, Ying A, Habra M, Thosani S, Hu M, Cabanillas M. Is Second-Line Targeted Therapy Beneficial in Patients (pts) with Differentiated Thyroid Cancer (DTC) After First-Line Sorafenib (SOR) Failure?. American Thyroid Association, 2013. e-Pub 2013.
Dadu R, Thosani SN, Nalini R. The Hyperinsulinism Hyperammonemia Syndrome Complicated by Gestational Diabetes Mellitus, 2012. e-Pub 2012.
Thosani SN, Busaidy N, Cabanillas M, Cote G, Grubbs E, Habra MA, Hu M, Perrier N, Ayala-Ramirez M, Rich T, Waguespack SG, Ying AK, Jimenez CJ. Characterization of Pheochromcoytomas in MEN 2 with RET codon 918 and 634 mutations, 2012. e-Pub 2012.
Thosani SN, Waguespack SG, Lavis VA, Jimenez C. Interleukin-2 Therapy and the Extremes of Autoimmune Thyroid Disease, 2011. e-Pub 2011.
Thosani SN, Edeiken-Monroe B, Jimenez C. Leukemic infiltration of the Thyroid Gland, 2011. e-Pub 2011.
Asfandiyar, Samina, Kaplan J, Rao a, Palma D, Thosani S. Impact of Preoperative Insulin Education on Outcomes After Total Pancreatectomy. ADCES 2026.
Grami P, Balajadia B, Guk-Ong B, Williams D, Jameel F, Tryels K, Gore S, Sonali Thosani MD. Improving Inpatient Glycemic Safety in Oncology Through a Nurse-Led Glycemic Management Resource Nurse Program. Association of Critical Care Nurses - Houston Gulf Coast.

Book Chapters

Thosani S. Endocrine and Metabolic Complications of Cancer Therapy. In: MD Anderson Manual of Medical Oncology. 2. McGraw Hill, 2025.
Hosein R, Bedrose S, Jeun R, Varghese JM, Thosani SN. Endocrine and Metabolic Complications of Cancer Therapy. In: The MD Anderson Manual of Medical Oncology. Fourth Edition. McGraw Hill, 2022.
Sarimar A, Thosani SN. Thyroid Emergencies in Critically Ill Cancer Patients. In: Oncologic Critical Care. 1. Springer, 1200-1205, 2019.
Thosani SN, Hu M, Ahn P, Lamont J. Thyroid and Parathyroid Cancers. In: Cancer Management: A Multidisciplinary Approach. 1. The Oncology Group, 1084, 2011.
Chaudhri A, Thosani S. Thyroid emergencies in Critically Ill Cancer Patients. In: Oncological Critical Care Textbook. Springer Hill.
Patel M, Khan Safia, Horng M, Khan Sonya, Thosani S. Hyperglycemic Emergencies in Critically Ill Cancer Patients. In: Oncologic Critical Care Textbook. Springer Hill.

Letters to the Editor

Thosani N, Thosani SN, Singh H, Guha S. Reply to I.H. Sahin. Journal of Clinical Oncology, 2013.

Web Publications

Thosani S, Alkon C. What to Do When It's Diabetes and Cancer; https://diatribe.org/diabetes-management/what-do-when-its-diabetes-and-cancer.